NEWS

CSL valuation pumping via blood rush despite ozempic effect

MELBOURNE: A casual visitor to the ASX from another universe watching CSL’s valuation ... read more

Neuren Pharma tumbles 14pc on short-seller report

NEW YORK: Neuren Pharmaceuticals has rebuked a short seller report targeting its US-listed ... read more

Schizophrenia fears as medical cannabis psychosis figures revealed

SURFERS PARADISE: A shocking numbers of patients who have never had a mental ... read more

Star share price plunges 22pc and delay to results announced

SYDNEY: Gaming group Star Entertainment is down nearly 20 per cent in ... read more